Ontario Cannabis Sales
Nov, 2024
Overview
The cannabis market in Ontario has shown a complex pattern of growth and pricing dynamics as of November 2024. With an average item price of $21.53, slightly down from $21.73 in October 2024, the market is experiencing a slight decrease in both sales and unit growth, with month-over-month sales growth at -3.6% and unit growth at -2.7%. Despite these monthly declines, the year-over-year sales growth is only slightly negative at -2.4%, suggesting a relatively stable market over the past year. The total sales for November 2024 reached approximately $169.9 million, indicating a significant market size within Canada.
In comparison to other provinces, Ontario maintains a leading position in terms of total sales volume, far surpassing other regions like Alberta ($82.1 million) and British Columbia ($57.1 million). This indicates a robust consumer base and a well-established market infrastructure that supports higher sales volumes despite the recent slight downturns in growth rates.
Nov, 2024
Sales
Year Over Year
Growth
Market Comparison
When comparing Ontario to other major markets in Canada, it is evident that Ontario not only leads in terms of total sales but also shows a unique resilience in certain categories like Tincture & Sublingual. The average item prices across different provinces do not vary significantly, with Ontario at $21.53, Alberta at $21.69, and British Columbia at $21.72. However, the growth rates differ markedly, with Ontario showing a slight year-over-year decline in sales growth, whereas Alberta experienced an 11.5% increase.
Category Performance
The Tincture & Sublingual category in Ontario has demonstrated an exceptional growth trajectory, contrasting with the general market trends. In November 2024, this category saw a remarkable year-over-year sales growth of 97.9% and unit growth of 116.4%, with total sales reaching $97,460. The average item price stood at $28.11, showing a significant increase from the previous year. This category's performance is particularly notable in the segment of Breathstrips and Sublingual Pouches, which alone accounted for the entire category's sales.